Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Profound Medical Corp

PROF ✗ NOT COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Advanced Medical Equipment & Technology ·

USA Micro Cap Analyst: STRONG BUY

Last Close

$6.63

▼ -0.60%

Market Cap $240.01M · Vol 21.95K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$240.01M

Micro Cap

Div Yield

N/A

EPS Growth

+38.77%

YoY

RSI (14)

38.10

Momentum

Beta

0.69

vs Market

52W High

$8.95

25.92% below

52W Low

$3.78

75.40% above

Volume

21.95K

Avg 27.62K

P/B

4.29

Price-to-book

ROE

N/A

Return on equity

Free Float

95.61%

Public shares

Shariah Compliance8 STANDARDS

✗ Profound Medical Corp (PROF) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does PROF pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-10.53%

-6.62%

-7.92%

+0.45%

YTD

-15.76%

+19.68%

-30.58%

-56.52%

Financials & Valuation

TTM · Annual

Total Revenue	$16.10M
Net Income	$-42,570,000.00
Revenue Growth (YoY)	+12.30%
Gross Margin	70.77%
Operating Margin	-256.27%
Net Profit Margin	-264.44%
ROE	N/A
ROA · ROIC	-57.30% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	14.74
P/B	4.29
P/FCF	N/A
EPS Growth	+38.77%
Outstanding Shares	36.34M

Technical Indicators

50-Day SMA	$7.01
200-Day SMA	$6.85
RSI (14)	38.10
Beta	0.69
52-Week High	$8.95
52-Week Low	$3.78

Volume Today	21.95K
Avg Daily Volume (30D)	27.62K
Relative Volume	0.79x
Volatility (10D)	74.57
Volatility (30D)	56.71
Free Float	95.61%

Analyst Consensus

STRONG BUY

Current Price $6.63

Mean Target $11.05

52W Low$3.78 52W High$8.95

Current

Target

$3.78 $8.95

Current Analyst target

+66.67% upside potential · 5 analysts

Identifiers

ExchangeNasdaq

FIGIBBG0076T0BS9

ISINCA74319B5027

CountryCanada

Sub-IndustryAdvanced Medical Equipment & Technology (NEC)

Earnings DateNov 10, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

TMO Thermo Fisher Scientific Inc -1.28% DHR Danaher Corp -0.71% ISRG Intuitive Surgical Inc -1.68% BSX Boston Scientific Corp +0.27% EW Edwards Lifesciences Corp -1.04%

Company Profile

Profound Medical Corp. is a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), AI-enhanced planning, robotically driven transurethral ultrasound and closed-loop temperature feedback control. The TULSA procedure, performed using the TULSA-PRO system, has the potential of becoming a mainstream treatment modality across the entire prostate disease spectrum; ranging from low-, intermediate-, or high-risk prostate cancer; to hybrid patients suffering from both prostate cancer and benign prostatic hyperplasia (BPH); to men with BPH only; and also, to patients requiring salvage therapy for radio-recurrent localized prostate cancer. It is also commercializing Sonalleve, a therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases.